| Issue Date | Title | Author(s) |
| 2019-12 | Dynamics of Prolyl Hydroxylases Levels During Disease Progression in Experimental Colitis. | Bakshi, HA; Mishra, V; Satija, S; Mehta, M; Hakkim, FL; Kesharwani, P; Dua, K; Chellappan, DK; Charbe, NB; Shrivastava, G; Rajeshkumar, S; Aljabali, AA; Al-Trad, B; Pabreja, K; Tambuwala, MM |
| 2020-01 | Nucleic Acid Aptamers as a Potential Nucleus Targeted Drug Delivery System. | Shrivastava, G; Bakshi, HA; Aljabali, AA; Mishra, V; Hakkim, FL; Charbe, NB; Kesharwani, P; Chellappan, DK; Dua, K; Tambuwala, MM |
| 2021-08 | Overview of key molecular and pharmacological targets for diabetes and associated diseases | Shahcheraghi, SH; Aljabali, AAA; Al Zoubi, MS; Mishra, V; Charbe, NB; Haggag, YA; Shrivastava, G; Almutary, AG; Alnuqaydan, AM; Barh, D; Dua, K; Chellappan, DK; Gupta, G; Lotfi, M; Serrano-Aroca, Á; Bahar, B; Mishra, YK; Takayama, K; Panda, PK; Bakshi, HA; Tambuwala, MM |
| 2020-01-01 | Small interfering RNA for cancer treatment: overcoming hurdles in delivery | Charbe, NB; Amnerkar, ND; Ramesh, B; Tambuwala, MM; Bakshi, HA; Aljabali, AAA; Khadse, SC; Satheeshkumar, R; Satija, S; Metha, M; Chellappan, DK; Shrivastava, G; Gupta, G; Negi, P; Dua, K; Zacconi, FC |
| - | Targeting LIN28: a new hope in prostate cancer theranostics | Shrivastava, G; Aljabali, AAA; Shahcheraghi, SH; Lotfi, M; Shastri, MD; Shukla, SD; Chellappan, DK; Jha, NK; Anand, K; Dureja, H; Pabari, RM; Mishra, V; Almutary, AG; Alnuqaydan, AM; Charbe, N; Prasher, P; Negi, P; Goyal, R; Dua, K; Gupta, G; Serrano-Aroca, Á; Bahar, B; Barh, D; Panda, PK; Takayama, K; Lundstorm, K; McCarron, P; Bakshi, H; Tambuwala, MM |
